Combined corticosteroid and long‐acting beta(2)‐agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

BACKGROUND: Both long‐acting beta(2)‐agonists (LABA) and inhaled corticosteroids (ICS) have been recommended in guidelines for the treatment of chronic obstructive pulmonary disease (COPD). Their coadministration in a combination inhaler may facilitate adherence to medication regimens and improve ef...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Nannini, Luis Javier, Poole, Phillippa, Milan, Stephen J, Holmes, Rebecca, Normansell, Rebecca
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2013
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6485527/
https://ncbi.nlm.nih.gov/pubmed/24214176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003794.pub4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky